- Home
- LBTYA vs ASND Comparison
LBTYA vs ASND Comparison
Compare LBTYA & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LBTYA
- ASND
- Stock Information
- Founded
- LBTYA 2004
- ASND 2006
- Country
- LBTYA Bermuda
- ASND Denmark
- Employees
- LBTYA N/A
- ASND N/A
- Industry
- LBTYA Cable & Other Pay Television Services
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- LBTYA Telecommunications
- ASND Health Care
- Exchange
- LBTYA Nasdaq
- ASND Nasdaq
- Market Cap
- LBTYA 4.1B
- ASND 10.6B
- IPO Year
- LBTYA N/A
- ASND 2015
- Fundamental
- Price
- LBTYA $11.78
- ASND $197.24
- Analyst Decision
- LBTYA Buy
- ASND Strong Buy
- Analyst Count
- LBTYA 5
- ASND 16
- Target Price
- LBTYA $14.96
- ASND $240.75
- AVG Volume (30 Days)
- LBTYA 1.7M
- ASND 394.0K
- Earning Date
- LBTYA 10-30-2025
- ASND 11-13-2025
- Dividend Yield
- LBTYA N/A
- ASND N/A
- EPS Growth
- LBTYA N/A
- ASND N/A
- EPS
- LBTYA N/A
- ASND N/A
- Revenue
- LBTYA $4,633,000,000.00
- ASND $576,332,355.00
- Revenue This Year
- LBTYA $10.21
- ASND $102.31
- Revenue Next Year
- LBTYA $1.04
- ASND $76.44
- P/E Ratio
- LBTYA N/A
- ASND N/A
- Revenue Growth
- LBTYA 81.79
- ASND 54.50
- 52 Week Low
- LBTYA $9.03
- ASND $118.03
- 52 Week High
- LBTYA $21.56
- ASND $208.16
- Technical
- Relative Strength Index (RSI)
- LBTYA 59.01
- ASND 54.46
- Support Level
- LBTYA $11.44
- ASND $196.06
- Resistance Level
- LBTYA $12.01
- ASND $202.57
- Average True Range (ATR)
- LBTYA 0.28
- ASND 5.93
- MACD
- LBTYA -0.04
- ASND -1.13
- Stochastic Oscillator
- LBTYA 63.10
- ASND 35.62
About LBTYA Liberty Global Ltd.
Liberty Global is a holding company with interests in European telecom companies in the UK, the Netherlands, Belgium, Ireland, and Slovakia. Liberty owns the main cable network in each of these geographies and has pursued a strategy since 2016 to merge or partner with mobile network operators to be able to offer converged services. Liberty also owns minority stakes in other media, entertainment, and cloud companies.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.